1 Product identity
Ingredient risk
1 ingredient to use with caution

Folic Acid 400 mcg

BrandFoods PlusVitamin Tablet or Pill 7 ingredients 1 caution DSLD #72967
Net contents: 180 Tablet(s)
Target: Adults and Children 4 years and above
DSLD entry: 2017-04-25
2 Ingredients (7)
IngredientGroupSafety
FolateFolateConditionally Safe
Dicalcium PhosphateCalciumConditionally Safe
Microcrystalline CelluloseCellulose
Stearic AcidStearic Acid
Croscarmellose SodiumCroscarmellose Sodium
Magnesium StearateMagnesiumUse with Caution
SilicaSiliconGenerally Safe
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
⚠️ Use with caution — restricted in some markets
Magnesium — Severe deficiency (<0.50 mmol/L) causes secondary hypocalcemia and hypokalemia that will not correct until magnesium is repleted first [1].
3 Safety cross-reference
Folate — Conditionally Safe
⚠ May mask B12 deficiency
⚠ Colorectal cancer risk debated
Calcium — Conditionally Safe
⚠ Cardiovascular risk debated >1,000 mg/day
⚠ Kidney stones
Sodium — Limited Evidence
⚠ Hypertension
⚠ Fluid retention
Magnesium — Use with Caution
⚠ Diarrhea (especially oxide)
⚠ Accumulates in renal impairment
Silicon — Generally Safe
⚠ Very low toxicity
4 Label claims
• All Other
• Structure/Function
5 Data source
DSLD ID72967
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2017-04-25
6 More from Foods Plus
View Foods Plus Safety Scorecard → 28 products
Acidophilus 1 Billion CFUAcidophilus Pro-Biotic Blend With PectinAlpha Lipoic Acid 300 mgB-ComplexBiotin 1000 mcgCal-Mag
7 Cite this page
Vancouver
Pkhakadze G. Folic Acid 400 mcg — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 24]. Available from: https://supplement.ge/products/dsld-72967/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG